![open-access-img](/_next/image?url=/images/open-access.png&w=32&q=100)
![open-access-img](/_next/image?url=/images/open-access.png&w=32&q=100)
Author(s)
Fathi Nabila Alim,
Nadia D. Quartantri,
Rizka Ramadani
Publication year2022
Publication title
kesans
Resource typeJournals
PublisherRifa Institute
Background : Neonatal Respiratory Disease Syndrome (NRDS) still become the most cause of neonatal’s mortality and morbidity especially in premature infants. Antenatal betamethasone has positive effect on preventing NRDS. Objectives : We sought to perform a systematic review of the use of bethametasone in women at risk of preterm delivery associated with the incidence of NRDS articles over the past fifty years. Methods: A systematic review was performed on PubMed and Scopus search term “Pediatrics” and “Pregnancy”. Results: Four articles identified between 2016 and 2019 specifically addressed for the use of betamethasone in women at risk of preterm delivery associated with the incidence of NRDS. A total 1800 patients were included in these four studies. The success rate range from 87,4% to 100%. Conclusion: Overall, the use of betamethasone in women at risk of preterm delivery decrease the incidence of respiratory distress syndrome in newborn significantly.
Subject(s)betamethasone , biology , bronchopulmonary dysplasia , genetics , gestation , gestational age , incidence (geometry) , medicine , neonatal respiratory distress syndrome , obstetrics , optics , pediatrics , physics , pregnancy , preterm delivery , respiratory distress , surgery
Language(s)English
eISSN2808-7178
pISSN2808-7380
DOI10.54543/kesans.v1i5.55
Seeing content that should not be on Zendy? Contact us.